To support and expand these findings, we also proved a close relationship between MEG3 expression levels and modulation of cancer cell related processes in preclinical models of HGSOC, finally providing a new paradigm for developing therapeutic strategies for cancer treatment. Here, MEG3 is linked to cancer.